Who are we?
Our executive team has over 50 years of experience in market research, legal compliance, business intelligence and deploying mobile workforces. Our advisors include Harvard epidemiologies and accomplished CEOs across a variety of the industries we service.
CEO and Co-Founder
Chief Operating Officer
Kimberly has 20 years of experience in leading and growing businesses. She has designed deeply complex programs that facilitate the gathering of customer and business intelligence in the field for enterprise companies. Kimberly is well versed on building strategic programs for companies that capture and measure the customer and brand experience, so that businesses can act upon the ever newly evolving expectations of customer experience.
Aleathia has over 20 years of experience in various operating leadership roles within the industries of real estate, renewable energy and investment banking. Company sizes throughout her career have ranged from large public companies, to family offices, to start-ups. Most recently, Ms. Hoster served as a Managing Partner with HB Partners, where she led operations, due diligence/underwriting and client services.
Director of Quality Control
Rebecca has over 10 years of experience offering strategic operational and quality assurance support to complex businesses, and their clients. She has worked within several market research and business services firms, and brings an in depth level of expertise around quality control and processes as it relates to the deliverables received by clients.
Dr. Michael Mina
Chief Science Officer, eMed, and Leading Epidemiologist
Dr. Christine Crawford
PH.D EPIDEMIOLOGY - HARVARD UNIVERSITY; FORMER CDC OFFICER
Founder and CEO of PayTech Trust
Dr. Michael Mina, MD, PhD is an Assistant Professor of Epidemiology at Harvard T. H. Chan School of Public Health and a core member of the Center for Communicable Disease Dynamics (CCDD). He is also an Assistant Professor in Immunology and Infectious Diseases at HSPH and Associate Medical Director in Clinical Microbiology (molecular diagnostics) in the Department of Pathology at Brigham and Women’s Hospital, Harvard Medical School. Currently he holds the position of Chief Science Officer in eMed